Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries

European Urology

Volumn 70, Issue 5, 2016, Pages 862-874

  Wong, Martin C S ^a   Goggins, William B ^b   Wang, Harry H X ^c,d   Fung, Franklin D H ^a   Leung, Colette ^a   Wong, Samuel Y S ^a   Ng, Chi Fai ^b   Sung, Joseph J Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c SUN YAT SEN UNIVERSITY   (China)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Age standardized rate; Incidence; Mortality; Prostate cancer; Temporal trend

Indexed keywords

ADULT; AGED; ARTICLE; ASIA; CANCER INCIDENCE; CANCER MORTALITY; EASTERN EUROPE; FEDERATED STATES OF MICRONESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYNESIA; PRIORITY JOURNAL; PROSTATE CANCER; REGISTER; SOCIOECONOMICS; STANDARDIZATION; UNITED STATES; WESTERN EUROPE; WORLD HEALTH ORGANIZATION; AGE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FACTUAL DATABASE; FEMALE; GLOBAL HEALTH; INCIDENCE; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; STATISTICS AND NUMERICAL DATA; TRENDS;

ADULT; AGE FACTORS; AGED; DATABASES, FACTUAL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; GLOBAL HEALTH; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PROSTATIC NEOPLASMS; SOCIOECONOMIC FACTORS; WORLD HEALTH ORGANIZATION;

EID: 84973460161     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2016.05.043     Document Type: Article

References (30)

1. [1] Ferlay, J., Soerjomataram, I., Ervik, M., et al. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide. IARC cancer base no. 11. 2013, International Agency for Research on Cancer, Lyon, France.
2. [2] Platz, E.A., Giovannucci, E., Prostate cancer. Schottenfeld, D., Fraumeni, J.F., (eds.) Cancer epidemiology and prevention, 2006, Oxford University Press, New York, NY, 1128–1150.
3. [3] Ng, C.F., Chiu, P.K.F., Lam, N.Y., Lam, H.C., Lee, K.W.M., Hou, S.S.M., The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4–10 ng/ml. Int Urol Nephrol 46 (2014), 711–717.
4. [4] Grönberg, H., Adolfsson, J., Aly, M., et al. Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study. Lancet 16 (2015), 1667–1676.
5. [5] Hsing, A.W., Tsao, L., Devesa, S.S., International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85 (2000), 60–70.
6. [6] Hsing, A.W., Devesa, S.S., Trends and patterns of prostate cancer: what do they suggest?. Epidemiol Rev 23 (2001), 3–13.
7. [7] Oliver, S.E., May, M.T., Gunnell, D., International trends in prostate-cancer mortality in the “PSA ERA”. Int J Cancer 92 (2001), 893–898.
8. [8] Center, M.M., Jemal, A., Lortet-Tieulent, J., et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 61 (2012), 1079–1092.
9. [9] Zhou, C.K., Check, D.P., Lortet-Tieulent, J., et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer 138 (2016), 1388–1400.
10. [10] Fontes, F., Severo, M., Castro, C., et al. Model-based patterns in prostate cancer mortality worldwide. Br J Cancer 108 (2013), 2354–2366.
11. [11] Arnold, M., Sierra, M.S., Laversanne, M., et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut, 2016, 10.1136/gutjnl-2015-310912.
12. [12] Howrey, B.T., Kuo, Y.-F., Lin, Y.-L., et al. The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States. J Gerontol A Biol Sci Med Sci 68 (2013), 56–61.
13. [13] Lyratzopoulos, G., Barbiere, J.M., Greenberg, D.C., et al. Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey. Br Med J, 340, 2010, c1928.
14. [14] United Nations Development Programme. Human development report 2013. The rise of the south: human progress in a diverse world. New York, NY: United Nations; 2013.
15. [15] Forman, D., Bray, F., Brewster, D.H., et al. Cancer incidence in five continents, Vol. X (electronic version). 2013, International Agency for Research on Cancer, Lyon, France http://ci5.iarc.fr.
16. [16] Surveillance, Epidemiology, and End Results Program. SEER*Stat database: incidence—SEER 9 regs research data, November 2013 Sub (1992-2011). www.seer.cancer.gov.
17. [17] New Zealand National Ministry of Health. NZ health statistics. www.health.govt.nz/nz-health-statistics.
18. [18] Australian Institute of Health and Welfare. Cancer in Australia. www.aihw.gov.au.
19. [19] Steliarova-Foucher E, O'Callaghan M, Ferlay J, et al. European Cancer Observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0. International Agency for Research on Cancer. http://eco.iarc.fr.
20. [20] Engholm G, Ferlay J, Christensen N, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 7.1. Association of the Nordic Cancer Registries. www.ancr.nu/cancer-data/.
21. [21] Mathers, C.D., Fat, D.M., Inoue, M., et al. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ 83 (2005), 171–177.
22. [22] Segi, M., Fujisaku, S., Kurihara, M., Geographical observation on cancer mortality by selected sites on the basis of standardised death rate. Gan 48 (1957), 219–225.
23. [23] Kim, H.-J., Fay, M.P., Feuer, E.J., et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19 (2000), 335–351.
24. [24] Clegg, L.X., Hankey, B.F., Tiwari, R., et al. Estimating average annual percent change in trend analysis. Stat Med 28 (2009), 3670–3682.
25. [25] DeSantis, C.E., Bray, F., Ferlay, J., et al. International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 24 (2015), 1–12.
26. [26] Kvale, R., Auvinen, A., Adami, H.O., et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 99 (2007), 1881–1887.
27. [27] Hankey, B.F., Feuer, E.J., Clegg, L.X., et al. Cancer surveillance series: interpreting trends in prostate cancer – part I: evidence of the effects of screening in recent prostate cancer incidence mortality and survival rates. J Natl Cancer Inst 91 (1999), 1017–1024.
28. [28] Ferlay, J., Soerjomataram, I., Dikshit, R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
29. [29] Kuruma, H., Egawa, S., Re: International variation in prostate cancer incidence and mortality rates. Eur Urol 63 (2013), 583–584.
30. [30] Parkin, D.M., Bray, F., Ferlay, I., et al. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prevent 23 (2014), 953–966.